PBX3 and acute myeloid leukemia: High expression of PBX3 was associated with poor prognosis in AML patients. PBX3 knockdown improved the survival of leukemic mice and reduced the leukaemia burden via decreasing the capacity of LSCs and promoting LSC apoptosis.